The cancer drugs that could improve survival rates if given to patients in the morning

A study has found that people with terminal lung or skin cancers lived twice as long if they received ­immunotherapy drugs – at the start of the day instead of after lunchtime.A study has found that people with terminal lung or skin cancers lived twice as long if they received ­immunotherapy drugs – at the start of the day instead of after lunchtime.Read MoreHealth News | Mail Online